Navigation Links
Which diabetes drug is best for diabetics with kidney disease?
Date:11/12/2011

Highlights

  • Sitagliptin is as effective as glipizide at lowering blood sugar levels in patients with type 2 diabetes and chronic kidney disease.
  • Sitagliptin is less likely than glipizide to cause dangerously low blood sugar levels.
  • Patients on sitagliptin tend to lose weight, while those on glipizide gain weight.

Some blood-sugar-lowering drugs have caused kidney problems in patients with type 2 diabetes, so physicians are especially cautious when prescribing these agents to diabetics who also have chronic kidney disease (CKD).

Previous research indicates that the diabetes drugs sitagliptin and glipizide may not cause considerable kidney damage. New clinical trial results presented during the American Society of Nephrology's Annual Kidney Week compared the two drugs.

Sitagliptin and glipizide act on different targets but generate the same resultthey boost the effects of insulin, which lowers blood sugar levels.

Juan Arjona Ferreira, MD, (MSD Corp.) and his colleagues conducted a 54-week study to compare the efficacy and safety of sitagliptin and glipizide in patients with type 2 diabetes and moderate or severe CKD who were not on dialysis. The researchers randomized 426 patients to receive sitagliptin or glipizide.

Among the major findings at the end of the study:

  • Blood glucose levels dropped to a similar extent in patients in both groups.
  • Patients receiving sitagliptin were less likely to experience hypoglycemiaor dangerously low blood sugar levelsthan patients receiving glipizide (6.2% vs 17.0%).
  • Patients who took sitagliptin tended to lose a small amount of weight, while most patients who took glipizide experienced a slight weight gain.


'/>"/>

Contact: Shari Leventhal
sleventhal@asn-online.org
202-503-7804
American Society of Nephrology
Source:Eurekalert

Page: 1

Related medicine news :

1. Registry: Do medications which reduce angina
2. No Headway Against COPD, Which Now Affects Women More
3. New Tests Could Spot Which Kidney Patients Will Do the Worst
4. Using MRI, researchers may predict which adults will develop Alzheimers
5. Does selenium prevent cancer? It may depend on which form people take
6. Which side of the brain rotates a mental picture?
7. Which symptoms of PTSD do the most damage?
8. Grant to study how to stop fumbled handoffs which can lead to medical errors
9. Gene test shows which bladder cancer patients may have cancer spread
10. Tomatoes found to contain nutrient which prevents vascular diseases
11. Which comes first: Exercise-induced asthma or obesity?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... ... June 27, 2017 , ... PR ... an upcoming case studies guidebook. This guidebook offers an excellent branding and exposure ... include articles, case studies and how-to’s that fall into the following categories:, ...
(Date:6/27/2017)... ... , ... Dr. Richard Amato, a respected periodontist in Monroe, CT, ... Implant Center of Connecticut. As part of the renovation, the cutting-edge practice added two ... to improve patient comfort while making it possible for Dr. Amato to provide even ...
(Date:6/27/2017)... North Hollywood, CA (PRWEB) , ... June 27, ... ... on orthodontic treatments . Orthodontics is a dental specialty that focuses on ... other appliances. Benefits include improved aesthetics and function. , North Hollywood ...
(Date:6/26/2017)... ... June 26, 2017 , ... Torrance dentist, Dr. Robert ... be one of the most noticeable aspects of a person’s appearance. A healthy, radiant ... is born with beautiful, balanced teeth, everyone can have the smile of their dreams ...
(Date:6/26/2017)... ... June 26, 2017 , ... The Centers for Advanced ... hiring of Richard Robinson as chief operating officer (COO). In this role, Robinson ... proven track record of simplifying business processes and developing growth strategies to increase ...
Breaking Medicine News(10 mins):
(Date:6/20/2017)... HILLS, Calif. , June 20, 2017 SkylineDx ... the use of MMprofiler with SKY92, the company,s prognostic ... In a poster presentation at the 22 nd ... Madrid, Spain , SkylineDx researchers will demonstrate ... patients. In a separate e-poster presentation ...
(Date:6/14/2017)... HAMPTON, Va. , June 14, 2017  ivWatch ... safety and effectiveness of intravenous (IV) therapy, is pleased ... in the category of Nonsurgical Hospital Supplies and Equipment ... premier awards program for the medtech industry. The award ... at the Jacob K. Javits Center in ...
(Date:6/11/2017)... June 10, 2017  Eli Lilly and Company (NYSE: ... Phase 3 studies of galcanezumab, an investigational treatment for ... data on several key secondary endpoints for galcanezumab compared ... these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be presented ... meeting in Boston . ...
Breaking Medicine Technology: